Congress trades

Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ · Healthcare · 6 congress trades · last filed 5 months ago

6
Congress disclosures shown
37d
Median delay on the congress disclosures
of the 45 day limit
5 buys·1 sell
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades LGND.

Free on iOS and Android.

About Ligand Pharmaceuticals Incorporated

from the company's filings and listing, as of Oct 24, 2026
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Chief executive
Todd C. Davis
Employees
47
Listed since
Nov 18, 1992
Market value
$6.1B
Price to earnings (12 mo)
30.3
Net income per share, as reported (12 mo)
$9.83
Dividend yield
-

www.ligand.com

Earnings

6 reported quarters · next on Oct 29, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 6, 2026$2.37$2.01$63.7M$61.3MEPS beatRevenue beat
Q1 FY2026reported May 14, 2026$1.63$1.84$51.7M$59.1MEPS missRevenue miss
Q4 FY2025reported Feb 26, 2026$2.02$1.46$59.7M$55.6MEPS beatRevenue beat
Q3 FY2025reported Nov 6, 2025$3.09$1.97$115.5M$58.7MEPS beatRevenue beat
Q2 FY2025reported Aug 7, 2025$1.60$1.42$47.6M$43.9MEPS beatRevenue beat
Q1 FY2025reported May 8, 2025$1.33$1.21$45.3M$38.7MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2024 · proxy filed Apr 22, 2025
ExecutiveSalaryStock awardsOtherTotal
Todd C. DavisChief Executive Officer$696K$6.4M$5.8M$12.9M
Tavo EspinozaChief Financial Officer$470K$1.4M$1.4M$3.3M
Andrew ReardonChief Legal Officer and Secretary$452K$1.4M$1.4M$3.3M

The summary compensation table from the proxy statement for fiscal 2024, with titles as filed then. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$980.2M3,100,996+4.7%15.46%
Invesco Ltd.$379.8M1,201,644+45.9%5.99%
Vanguard Portfolio Management LLC$359.8M1,138,316+3.5%5.67%
Jupiter Topco LLC$328.9M1,040,578New5.19%
Vanguard Capital Management LLC$275.3M870,950+2.7%4.34%
State Street Corp$261.3M826,539+6.1%4.16%
FMR LLC$241.1M762,827+28.0%3.80%
Franklin Templeton Inc$237.7M752,044+31.2%3.75%
Congress Asset Management Co$208.6M659,911+30.8%3.29%
Geode Capital Management, LLC$186.2M589,020+5.4%2.94%
Nomura Asset Management International Inc.$179.7M568,371-0.9%2.83%
Chicago Capital, LLC$174.9M553,435-1.5%2.76%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. New: not in this holder's prior 13F as reported; a change of filer ID can also show as new. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Know when the next LGND filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in LGND

6 disclosures of 6 on record · median 37d of the 45 allowed

Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.

MemberTypeActionAmount disclosedStock since the tradeTrade dateDisclosedDelay
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+30.9%S&P 500 +0.4% · +30.4 pts vs S&P 500May 29, 2026Jun 8, 202610d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+48.6%S&P 500 +11.6% · +37.0 pts vs S&P 500Mar 3, 2026Apr 7, 202635d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+58.1%S&P 500 +10.5% · +47.6 pts vs S&P 500Jan 5, 2026Feb 13, 202639d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+54.8%S&P 500 +9.7% · +45.1 pts vs S&P 500Jan 15, 2026Feb 13, 202629d
Katherine M. ClarkSpouseStockSale$1,001 - $15,000+258.2%After the saleS&P 500 +120.7% · +137.5 pts vs S&P 500Oct 22, 2020Dec 3, 202042d
Katherine M. ClarkSpouseStockPurchase$1,001 - $15,000+314.5%S&P 500 +206.4% · +108.1 pts vs S&P 500Apr 3, 2020May 29, 202056d

Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in LGND, filterable by party, chamber, type and account.

Members of Congress reporting a position

1 member · estimate, as of Oct 23, 2026

1 member reports a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Gilbert Ray Cisneros, Jr.Democrat · House$15,001 - $50,0000.1%

Estimate, as of Oct 23, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Which members of Congress have traded LGND?

Gilbert Ray Cisneros, Jr. and Katherine M. Clark disclosed LGND transactions in the filings shown here.

Which members of Congress hold LGND?

1 member of Congress reports a position in LGND in the estimate we hold as of Oct 23, 2026. The estimated position belongs to Gilbert Ray Cisneros, Jr. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are LGND trades disclosed?

Congressional disclosures took a median of 37 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 26, 2026.

Related companies

traded by the same members

See every company we track